Pain Management

Intensity of headache pain is as important as frequency when evaluating the clinical response and impact of migraine preventive treatment with OnabotulinumtoxinA on patient headache-related disability, according to a recent study.

Before coming to the clinic, they had been treated conservatively by primary care physicians and had suffered from pain anywhere from 2 to 40 years.

A recent review explored the mechanism of a 5-hydroxytryptamine (5-HT 1f) agonist used in the treatment of acute migraine pain.

Healthcare professionals report pain management barriers across system, provider, and patient levels, highlighting the need to consider chronic pain as a chronic condition that warrants coordinated approaches.

Our brains experience social and physical pain in much the same way; rural hospitals in the United States are increasingly at risk of closure; there is strong support for organ and tissue donation for research.

Migraine was the most common type of headache in patients with hyperprolactinemia.

The literature review examined randomized controlled trials for craniosacral therapy (CST) in patients with migraine and other conditions that cause pain.

Exercise can be a potent therapy for patients with rheumatologic diseases and can result in improvements in inflammation, disease activity score, pain, stiffness, and fatigue. However, exercise needs to be modified for these patients to address the unique barriers they may have compared with the general population, said panelists during a session at the American College of Rheumatology’s annual meeting.

Here are the top 5 articles for the month of October.

A recent study looked at the role of the cerebellum and brainstem in migraine pain.

Other than surgery and medications, including opioids, there are few options for treating pain symptoms, which affect more than half of all patients with neurofibromatosis type 1.

Researchers recommended strategies for providers to think about when managing this population.

According to the researchers, these rates are nearly double that seen in the general population, which suggests the presence of unmet needs among the survivorship community.

In recent years, fatal overdoses from fentanyl have drastically increased across the nation, with the number of deaths nearly doubling each year from 2013 through 2016.

A computer simulated cost-effectiveness model of fremanezumab for migraine found that it was cost effective versus no treatment. Researchers presented a poster about its cost-effectiveness for the prevention of chronic and episodic migraine at ISPOR 2019.

The analysis showed the opioid cessation rate at 18 months after surgery was 64% among those who used the pain medication before joint replacement, and 95% among those who did not.

According to a recent study, people with migraines may have altered connections between the somatosensory cortex and the frontal lobe compared with people who do not experience migraines.

A group of researchers systematically reviewed previously published literature about psychological treatment in primary headache and its effectiveness. The results were published in The Journal of Headache and Pain.